Abbott Unit's Injunction Bid Denied In Stent Spat

Law360, New York (September 30, 2008, 12:00 AM EDT) -- A federal judge denied a permanent injunction bid from an Abbot Laboratories subsidiary that took aim at Medtronic Inc.'s Endeavor drug-eluting stent, the latest development in a long-running battle over stent patents.

Judge Sue Robinson of the U.S. District Court for the District of Delaware denied plaintiff Advanced Cardiovascular Systems Inc.'s bid for a permanent injunction on Friday, and declined to enjoin Medtronic's production of its Endeavor stent, which the court said infringes ACS' patents because it incorporates the “Driver” stent.

Court papers say that ACS...
To view the full article, register now.